PepGen (PEPG) Tax Provisions (2022 - 2026)

PepGen (PEPG) posted Tax Provisions of $15000.0 for Q1 2026, up 102.08% sequentially from -$720000.0 in Q4 2022.

Analysis

PepGen (PEPG) Tax Provisions (2022 - 2026) Analysis & Trends

PepGen has reported Tax Provisions for 2 years, with the latest figure at $15000.0 in Q1 2026.

Quarterly Tax Provisions changed N/A year-over-year to $15000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$685000.0 (up 4.86% YoY) and the FY2025 annual result came in at $49000.0, up 107.94% from the prior year.
Tax Provisions rose to $15000.0 in Q1 2026 per PEPG's latest filing, from -$720000.0 in the prior quarter.
Over five years, Tax Provisions peaked at $4.4 million in Q1 2022 and troughed at -$720000.0 in Q4 2022.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-59.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	15.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	75.45 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	13.31 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	1.90 Mn
10	PepGen	217.99 Mn	217.99 Mn	-	16,000.00

Historic Data

Download Data